These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 20384436

  • 21. Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study.
    Winther K, Rein E, Hedman C.
    Climacteric; 2005 Jun; 8(2):162-70. PubMed ID: 16096172
    [Abstract] [Full Text] [Related]

  • 22. Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women.
    Visvanathan K, Gallicchio L, Schilling C, Babus JK, Lewis LM, Miller SR, Zacur H, Flaws JA.
    Obstet Gynecol; 2005 Dec; 106(6):1372-81. PubMed ID: 16319265
    [Abstract] [Full Text] [Related]

  • 23. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life.
    Gupta P, Sturdee DW, Palin SL, Majumder K, Fear R, Marshall T, Paterson I.
    Climacteric; 2006 Feb; 9(1):49-58. PubMed ID: 16428125
    [Abstract] [Full Text] [Related]

  • 24. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J, Graeser T, Mellinger U, Ertan K, Holz C.
    Maturitas; 2007 Oct 20; 58(2):201-7. PubMed ID: 17889463
    [Abstract] [Full Text] [Related]

  • 25. Postmenopausal hot flushes and bone mineral density: a longitudinal study.
    Tuomikoski P, Ylikorkala O, Mikkola TS.
    Acta Obstet Gynecol Scand; 2015 Feb 20; 94(2):198-203. PubMed ID: 25421213
    [Abstract] [Full Text] [Related]

  • 26. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study.
    D'Anna R, Cannata ML, Atteritano M, Cancellieri F, Corrado F, Baviera G, Triolo O, Antico F, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Marini H, Squadrito F.
    Menopause; 2007 Feb 20; 14(4):648-55. PubMed ID: 17251874
    [Abstract] [Full Text] [Related]

  • 27. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S, Walsh BW, Ciaccia AV, Siddhanti S, Rosen AS, Plouffe L.
    Obstet Gynecol; 2004 Feb 20; 103(2):267-73. PubMed ID: 14754694
    [Abstract] [Full Text] [Related]

  • 28. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 Feb 20; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 29. First time proof of sage's tolerability and efficacy in menopausal women with hot flushes.
    Bommer S, Klein P, Suter A.
    Adv Ther; 2011 Jun 20; 28(6):490-500. PubMed ID: 21630133
    [Abstract] [Full Text] [Related]

  • 30. Cardiac repolarization in recently postmenopausal women with or without hot flushes.
    Lantto H, Mikkola TS, Tuomikoski P, Viitasalo M, Väänänen H, Sovijärvi AR, Haapalahti P.
    Menopause; 2016 May 20; 23(5):528-34. PubMed ID: 26599687
    [Abstract] [Full Text] [Related]

  • 31. Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate.
    Palacios S, Farias ML, Luebbert H, Gomez G, Yabur JA, Quail DC, Turbi C, Kayath MJ, Almeida MJ, Mönnig E, Nickelsen T.
    Am J Obstet Gynecol; 2004 Jul 20; 191(1):121-31. PubMed ID: 15295352
    [Abstract] [Full Text] [Related]

  • 32. Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women.
    Utian W, Yu H, Bobula J, Mirkin S, Olivier S, Pickar JH.
    Maturitas; 2009 Aug 20; 63(4):329-35. PubMed ID: 19647382
    [Abstract] [Full Text] [Related]

  • 33. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.
    D'Anna R, Cannata ML, Marini H, Atteritano M, Cancellieri F, Corrado F, Triolo O, Rizzo P, Russo S, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Adamo EB, Squadrito F.
    Menopause; 2009 Aug 20; 16(2):301-6. PubMed ID: 19034051
    [Abstract] [Full Text] [Related]

  • 34. The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in post-menopausal women.
    Malacara JM, Pérez-Luque EL, Martínez-Garza S, Sánchez-Marín FJ.
    Maturitas; 2004 Oct 15; 49(2):163-9. PubMed ID: 15474761
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
    Speroff L, Gass M, Constantine G, Olivier S, Study 315 Investigators.
    Obstet Gynecol; 2008 Jan 15; 111(1):77-87. PubMed ID: 18165395
    [Abstract] [Full Text] [Related]

  • 36. Menopausal symptoms are associated with subclinical atherosclerosis in healthy recently postmenopausal women.
    Lambrinoudaki I, Augoulea A, Armeni E, Rizos D, Alexandrou A, Creatsa M, Kazani M, Georgiopoulos G, Livada A, Exarchakou A, Stamatelopoulos K.
    Climacteric; 2012 Aug 15; 15(4):350-7. PubMed ID: 22132748
    [Abstract] [Full Text] [Related]

  • 37. Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women.
    Archer DF, EstroGel Study Group.
    Menopause; 2003 Aug 15; 10(6):516-21. PubMed ID: 14627859
    [Abstract] [Full Text] [Related]

  • 38. A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol.
    Gass MS, Rebar RW, Cuffie-Jackson C, Cedars MI, Lobo RA, Shoupe D, Judd HL, Buyalos RP, Clisham PR.
    Maturitas; 2004 Oct 15; 49(2):140-7. PubMed ID: 15474758
    [Abstract] [Full Text] [Related]

  • 39. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.
    Williams RE, Kalilani L, DiBenedetti DB, Zhou X, Granger AL, Fehnel SE, Levine KB, Jordan J, Clark RV.
    Climacteric; 2008 Feb 15; 11(1):32-43. PubMed ID: 18202963
    [Abstract] [Full Text] [Related]

  • 40. Medroxyprogesterone and conjugated oestrogen are equivalent for hot flushes: a 1-year randomized double-blind trial following premenopausal ovariectomy.
    Prior JC, Nielsen JD, Hitchcock CL, Williams LA, Vigna YM, Dean CB.
    Clin Sci (Lond); 2007 May 15; 112(10):517-25. PubMed ID: 17419685
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.